BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Pharm Country

  NexMed Receives NASDAQ Delisting Warning Letter

  October 10, 2006

   · 

  1 min read
• Business

  Holmes BioPharma-Big Pharma Inspects Omaha

  October 10, 2006

   · 

  1 min read
• Drug Development

  Myogen Release: Four Ambrisentan Studies To Be Presented At Chest 2006 Salt Lake City

  October 10, 2006

   · 

  1 min read
• Business

  Radlink Signs Agreement With X-Ray Visions To Serve As CR Pro(TM) Master Distributor For Maryland, Virginia And Washington, D.C.

  October 10, 2006

   · 

  1 min read
• Business

  SpectRx, Inc. Director Chris Monahan Retires

  October 10, 2006

   · 

  1 min read
• Business

  Lorus Therapeutics Inc. Reports First Quarter Results For Fiscal Year 2007

  October 10, 2006

   · 

  9 min read
• Biotech Beach

  NEW MEDICINE Release: Oncology Drug Development Update; Targeting The Epidermal Growth Factor Receptor (EGFr) Signal Transduction Pathway

  October 10, 2006

   · 

  3 min read
• Business

  Johnson & Johnson To Host Analyst Conference Call On Third-Quarter Results

  October 10, 2006

   · 

  1 min read
• Drug Development

  Inspire Pharmaceuticals, Inc. Begins Phase 2 Clinical Program Of Epinastine For Seasonal Allergic Rhinitis

  October 10, 2006

   · 

  1 min read
• Drug Development

  The Immune Response Corporation, Inc. Secures Key Partners For Launch Of Phase II Trial Of NeuroVax(TM) In Patients With Multiple Sclerosis

  October 10, 2006

   · 

  8 min read